Minerva Surgical Announces Change of Date for Third Quarter 2022 Earnings Release and Conference Call

Rhea-AI Summary

Minerva Surgical, Inc. (Nasdaq: UTRS) has announced a new date for its earnings conference call, now scheduled for November 14, 2022. The call will cover the company's third quarter 2022 financial results and recent highlights, taking place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Interested participants must register in advance for dial-in access. Minerva Surgical focuses on developing minimally invasive solutions for Abnormal Uterine Bleeding (AUB) and offers alternatives to hysterectomy.

Positive

• Focus on minimally invasive solutions for women's health issues.
• Active in addressing AUB, a significant healthcare concern for women.

Negative

• None.

SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc. (Nasdaq: UTRS), a woman’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has changed the date of its previously announced earnings conference call. It will now report its third quarter 2022 financial results on Monday, November 14, 2022. In conjunction with the release, the company will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

To access the live call via telephone, please register in advance using the link here. Upon registering, each participant will receive an email confirmation with dial-in numbers and a unique personal PIN that can be used to join the call.

The live webinar of the call may be accessed by visiting the Recent Events section of the company’s website at http://ir.minervasurgical.com. A replay of the webinar will be available on the Company’s website shortly after the conclusion of the call.

About Minerva Surgical, Inc.

Minerva Surgical is a commercial-stage medical technology company focused on developing, manufacturing, and commercializing minimally invasive solutions to meet the distinct uterine healthcare needs of women. The Company has established a broad product line of commercially available, minimally invasive alternatives to hysterectomy, which are designed to address the most common causes of Abnormal Uterine Bleeding (AUB) in most uterine anatomies. The Minerva Surgical solutions can be used in a variety of medical treatment settings and aim to address the drawbacks associated with alternative treatment methods and to preserve the uterus by avoiding unnecessary hysterectomies.

MEDIA CONTACT

Mike Clapper
mike.clapper@minervasurgical.com 
804-295-7676

INVESTOR RELATIONS CONTACT

Caroline Corner
investors@minervasurgical.com 
415-202-5678

RELATED LINKS

https://www.aubandme.com

https://www.minervasurgical.com

FAQ

When will Minerva Surgical report its Q3 2022 earnings?

Minerva Surgical will report its Q3 2022 earnings on November 14, 2022.

What time will Minerva Surgical's earnings conference call take place?

The earnings conference call will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

How can I access the live call for Minerva Surgical's earnings?

Participants can register in advance to access the live call by following the provided link in the press release.

What is Minerva Surgical's focus in women's healthcare?

Minerva Surgical is focused on developing minimally invasive solutions for Abnormal Uterine Bleeding (AUB).